Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Onyx’s Cancer Drug’s Risk May Outweigh Benefit, FDA Says
Bloomberg
Monday, June 18, 2012 - 11:04am
tags:
FDA, Onyx, Kyprolis, Multiple Myeloma
Infinity Pharmaceuticals stock plunges after company stops potential cancer treatment study
Yahoo/AP
Monday, June 18, 2012 - 10:56am
tags:
Infinity Pharmaceuticals, bone cancer, saridegib
Merck in potential $300M research deal with Ambrx
Yahoo/AP
Monday, June 18, 2012 - 10:53am
tags:
Ambrx, Merck, R&D
Drugmakers Don’t Owe Sales Force Overtime, Top Court Says
Bloomberg
Monday, June 18, 2012 - 10:51am
tags:
overtime lawsuits, Supreme Court, GSK
Abbott announced results of clinical studies evaluating Parkinson's treatment
Yahoo/Fly on the Wall
Monday, June 18, 2012 - 10:24am
tags:
Abbott Laboratories, Parkinson's Disease, levodopa-carbidopa intestinal gel
Mallinckrodt Announces Co-Promotion Arrangement for DUEXIS®
Yahoo
Monday, June 18, 2012 - 10:23am
tags:
Mallinckrodt, Duexis, Horizon Pharma
Takeda to stop selling 13 Pfizer drugs in Japan
Reuters
Monday, June 18, 2012 - 10:21am
tags:
Japan, Takeda
BIO convention comes back to Boston
Boston Globe, MA
Sunday, June 17, 2012 - 11:08am
tags:
Boston, BIO Conference
Piramal Healthcare seeks to buy U.S. drug maker
Marketwatch
Sunday, June 17, 2012 - 11:06am
tags:
Piramal Healthcare, Cambridge Major Laboratories, M&A, India
Analysts Debate: Is Life Technologies a Top Stock?
Motley Fool
Sunday, June 17, 2012 - 11:02am
tags:
Life Technologies
3 Reasons to Buy Arena Pharma
Motley Fool
Sunday, June 17, 2012 - 11:01am
tags:
Arena Pharmaceuticals
Otsuka, Bristol-Myers Squibb announce six-year data from SPRYCEL Phase 3 trial on CP-CML
news-medical.net
Saturday, June 16, 2012 - 2:12pm
tags:
Otsuka, Bristol-Myers Squibb, Sprycel, leukemia, chronic myeloid leukemia
Teva says MS drug met goals in clinical trial
PharmPro
Saturday, June 16, 2012 - 2:09pm
tags:
Teva Pharmaceuticals, Copaxone, multiple sclerosis
Insiders Bought 3 Plunging Healthcare Stocks Last Week, And 3 Other Noteworthy Buys And 5 Sells
Seeking Alpha
Saturday, June 16, 2012 - 1:54pm
tags:
Achillion, Allscripts, Targacept, Endo, United Therapeutics, Nanosphere
Raptor Pharma Rises as FDA Starts Drug Review
PharmPro
Saturday, June 16, 2012 - 1:52pm
tags:
RP103, Raptor Pharmaceuticals, nephropathic cystinosis
Alembic settles patent dispute with Novartis
Business Standard, India
Saturday, June 16, 2012 - 1:46pm
tags:
Alembic Pharmaceuticals, Breckenridge, Novartis, Exelon, generics, patents, lawsuits
Human Genome Goes Full Monty
Motley Fool
Saturday, June 16, 2012 - 1:40pm
tags:
Human Genome Sciences, M&A
A Long Shot In The Lupus Market Gains Attention
Seeking Alpha
Saturday, June 16, 2012 - 1:39pm
tags:
lupus, Anthera, blisibimod
Don't Sell: Pfizer Can Handle Crisis
Seeking Alpha
Saturday, June 16, 2012 - 1:38pm
tags:
Pfizer
Keep Your Eye On Merck
Seeking Alpha
Saturday, June 16, 2012 - 1:38pm
tags:
Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.